Jefferies Group started coverage on shares of Repligen Corp. (NASDAQ:RGEN) in a research report sent to investors on Tuesday morning, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $17.00 price target on the stock. Repligen Corporation (NASDAQ:RGEN) shares after opening at $15.30 moved to $16.22 on last trade day and at the end of the day closed at $15.84. Company price to sales ratio in past twelve months was calculated as 7.44 and price to cash ratio as 8.24. Repligen Corporation (NASDAQ:RGEN) showed a positive weekly performance of 15.79%.
As previously announced, on April 1, 2014, Scott D. Schweinfurth was named Executive Vice President and Chief Financial Officer of Scientific Games Corporation (NASDAQ:SGMS), succeeding Jeffrey S. Lipkin as Chief Financial Officer of the Company. Scientific Games Corp (NASDAQ:SGMS) shares advanced 0.53% in last trading session and ended the day on $11.46.SGMS return on equity ratio is recorded as -16.10% and its return on assets is -2.00%. Scientific Games Corp (NASDAQ:SGMS) yearly performance is 49.61%.
Aktiebolaget Svensk Exportkredit (Swed Ex Cred Corp) Elements (SM) Linked to the SPECTRUM Large Cap U.S. Sector Momentum Index developed by BNP Paribas due Augu (NYSEARCA:EEH) shares moved down -1.18% in last trading session and was closed at $11.71, while trading in range of $11.50 – $11.75. Aktiebolaget Svensk Exportkredit (Swed Ex Cred Corp) Elements (SM) Linked to the SPECTRUM Large Cap U.S. Sector Momentum Index developed by BNP Paribas due Augu (NYSEARCA:EEH) year to date (YTD) performance is 6.55%.
ProShares UltraShort Health Care (ETF) (NYSEARCA:RXD) weekly performance is 1.92%. On last trading day company shares ended up $23.94. ProShares UltraShort Health Care (ETF) (NYSEARCA:RXD) distance from 50-day simple moving average (SMA50) is 4.62%.